vs

Side-by-side financial comparison of BEYOND MEAT, INC. (BYND) and CASTLE BIOSCIENCES INC (CSTL). Click either name above to swap in a different company.

CASTLE BIOSCIENCES INC is the larger business by last-quarter revenue ($83.7M vs $61.6M, roughly 1.4× BEYOND MEAT, INC.). On growth, CASTLE BIOSCIENCES INC posted the faster year-over-year revenue change (-4.9% vs -19.7%). Over the past eight quarters, CASTLE BIOSCIENCES INC's revenue compounded faster (-1.9% CAGR vs -9.7%).

Beyond Meat, Inc., branded as Beyond, is a producer of plant-based meat alternatives founded in 2009 by Ethan Brown. The company's products were first launched in the United States in 2012.

Castle Biosciences Inc. is a commercial-stage diagnostic firm that develops and markets proprietary, clinically actionable tests for dermatological conditions such as melanoma and other skin cancers, plus rare diseases. It operates mainly in the U.S. healthcare market, focusing on segments with high unmet need for more accurate diagnostics to guide treatment choices.

BYND vs CSTL — Head-to-Head

Bigger by revenue
CSTL
CSTL
1.4× larger
CSTL
$83.7M
$61.6M
BYND
Growing faster (revenue YoY)
CSTL
CSTL
+14.8% gap
CSTL
-4.9%
-19.7%
BYND
Faster 2-yr revenue CAGR
CSTL
CSTL
Annualised
CSTL
-1.9%
-9.7%
BYND

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
BYND
BYND
CSTL
CSTL
Revenue
$61.6M
$83.7M
Net Profit
$-14.5M
Gross Margin
-11.5%
Operating Margin
-211.4%
Net Margin
-17.4%
Revenue YoY
-19.7%
-4.9%
Net Profit YoY
43.8%
EPS (diluted)
$0.68
$-0.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BYND
BYND
CSTL
CSTL
Q1 26
$83.7M
Q4 25
$61.6M
$87.0M
Q3 25
$70.2M
$83.0M
Q2 25
$75.0M
$86.2M
Q1 25
$68.7M
$88.0M
Q4 24
$76.7M
$86.3M
Q3 24
$81.0M
$85.8M
Q2 24
$93.2M
$87.0M
Net Profit
BYND
BYND
CSTL
CSTL
Q1 26
$-14.5M
Q4 25
Q3 25
$-110.7M
$-501.0K
Q2 25
$-29.2M
$4.5M
Q1 25
$-52.9M
$-25.8M
Q4 24
Q3 24
$-26.6M
$2.3M
Q2 24
$-34.5M
$8.9M
Gross Margin
BYND
BYND
CSTL
CSTL
Q1 26
Q4 25
-11.5%
79.0%
Q3 25
10.3%
77.5%
Q2 25
11.5%
79.5%
Q1 25
-1.5%
81.4%
Q4 24
13.1%
81.3%
Q3 24
17.7%
81.8%
Q2 24
14.7%
83.3%
Operating Margin
BYND
BYND
CSTL
CSTL
Q1 26
Q4 25
-211.4%
-4.4%
Q3 25
-160.0%
-8.2%
Q2 25
-46.6%
-4.9%
Q1 25
-81.8%
-31.7%
Q4 24
-49.3%
4.7%
Q3 24
-38.2%
5.9%
Q2 24
-36.4%
5.8%
Net Margin
BYND
BYND
CSTL
CSTL
Q1 26
-17.4%
Q4 25
Q3 25
-157.6%
-0.6%
Q2 25
-39.0%
5.2%
Q1 25
-77.0%
-29.4%
Q4 24
Q3 24
-32.8%
2.6%
Q2 24
-37.0%
10.3%
EPS (diluted)
BYND
BYND
CSTL
CSTL
Q1 26
$-0.49
Q4 25
$0.68
$-0.06
Q3 25
$-1.44
$-0.02
Q2 25
$-0.38
$0.15
Q1 25
$-0.69
$-0.90
Q4 24
$-0.65
$0.32
Q3 24
$-0.41
$0.08
Q2 24
$-0.53
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BYND
BYND
CSTL
CSTL
Cash + ST InvestmentsLiquidity on hand
$203.9M
$63.8M
Total DebtLower is stronger
$415.7M
$10.1M
Stockholders' EquityBook value
$-997.0K
$461.4M
Total Assets
$614.7M
$547.8M
Debt / EquityLower = less leverage
0.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BYND
BYND
CSTL
CSTL
Q1 26
$63.8M
Q4 25
$203.9M
$299.5M
Q3 25
$117.3M
$287.5M
Q2 25
$103.5M
$275.9M
Q1 25
$102.1M
$275.2M
Q4 24
$131.9M
$293.1M
Q3 24
$121.7M
$95.0M
Q2 24
$144.9M
$85.6M
Total Debt
BYND
BYND
CSTL
CSTL
Q1 26
$10.1M
Q4 25
$415.7M
$10.1M
Q3 25
$1.2B
$10.0M
Q2 25
$1.2B
$10.0M
Q1 25
$1.1B
$10.0M
Q4 24
$1.1B
$10.0M
Q3 24
$1.1B
$10.0M
Q2 24
$1.1B
$10.0M
Stockholders' Equity
BYND
BYND
CSTL
CSTL
Q1 26
$461.4M
Q4 25
$-997.0K
$470.9M
Q3 25
$-784.1M
$467.0M
Q2 25
$-677.0M
$455.4M
Q1 25
$-649.5M
$440.3M
Q4 24
$-601.2M
$455.8M
Q3 24
$-611.9M
$441.1M
Q2 24
$-590.0M
$423.9M
Total Assets
BYND
BYND
CSTL
CSTL
Q1 26
$547.8M
Q4 25
$614.7M
$578.6M
Q3 25
$599.7M
$562.8M
Q2 25
$691.7M
$544.7M
Q1 25
$643.8M
$501.7M
Q4 24
$678.1M
$531.2M
Q3 24
$692.9M
$514.6M
Q2 24
$711.2M
$487.3M
Debt / Equity
BYND
BYND
CSTL
CSTL
Q1 26
0.02×
Q4 25
0.02×
Q3 25
0.02×
Q2 25
0.02×
Q1 25
0.02×
Q4 24
0.02×
Q3 24
0.02×
Q2 24
0.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BYND
BYND
CSTL
CSTL
Operating Cash FlowLast quarter
$-46.8M
$-22.1M
Free Cash FlowOCF − Capex
$-49.8M
FCF MarginFCF / Revenue
-80.8%
Capex IntensityCapex / Revenue
4.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-157.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BYND
BYND
CSTL
CSTL
Q1 26
$-22.1M
Q4 25
$-46.8M
$26.9M
Q3 25
$-38.8M
$22.6M
Q2 25
$-33.2M
$20.8M
Q1 25
$-26.1M
$-6.0M
Q4 24
$-29.0M
$24.4M
Q3 24
$-22.0M
$23.3M
Q2 24
$-16.0M
$24.0M
Free Cash Flow
BYND
BYND
CSTL
CSTL
Q1 26
Q4 25
$-49.8M
$19.7M
Q3 25
$-41.7M
$7.8M
Q2 25
$-35.1M
$11.6M
Q1 25
$-30.6M
$-10.8M
Q4 24
$-35.4M
$16.8M
Q3 24
$-24.1M
$17.0M
Q2 24
$-17.3M
$18.8M
FCF Margin
BYND
BYND
CSTL
CSTL
Q1 26
Q4 25
-80.8%
22.7%
Q3 25
-59.4%
9.4%
Q2 25
-46.9%
13.4%
Q1 25
-44.6%
-12.2%
Q4 24
-46.2%
19.5%
Q3 24
-29.7%
19.8%
Q2 24
-18.6%
21.6%
Capex Intensity
BYND
BYND
CSTL
CSTL
Q1 26
Q4 25
4.8%
8.3%
Q3 25
4.1%
17.9%
Q2 25
2.6%
10.7%
Q1 25
6.5%
5.4%
Q4 24
8.4%
8.8%
Q3 24
2.5%
7.4%
Q2 24
1.4%
6.0%
Cash Conversion
BYND
BYND
CSTL
CSTL
Q1 26
Q4 25
Q3 25
Q2 25
4.60×
Q1 25
Q4 24
Q3 24
10.29×
Q2 24
2.69×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons